Decoy Therapeutics Inc. Research and Development Expense
Decoy Therapeutics Inc. (DCOY) reported Research and Development Expense of $1.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- Decoy Therapeutics Inc. research and development expense for the quarter ending 2026-06-30 was $1.30M, a 1020.73% increase year-over-year.
- Decoy Therapeutics Inc. research and development expense for the quarter ending 2026-03-31 was $749.81K, a 892.71% increase year-over-year.
- Decoy Therapeutics Inc. research and development expense for the quarter ending 2025-12-31 was $114.43K, a 34.74% decline year-over-year.
- Decoy Therapeutics Inc. research and development expense for the quarter ending 2025-09-30 was $61.83K, a 54.95% decline year-over-year.
- Decoy Therapeutics Inc. research and development expense for fiscal 2025 was $368.17K, a 52.19% decline from fiscal 2024.
- Decoy Therapeutics Inc. research and development expense for fiscal 2024 was $770.03K, a 89.27% decline from fiscal 2023.
- Decoy Therapeutics Inc. research and development expense for fiscal 2023 was $7.17M, a 54.70% decline from fiscal 2022.
- Decoy Therapeutics Inc. research and development expense for fiscal 2022 was $15.84M, a 85.26% increase from fiscal 2021.
| Period end | Research and Development Expense 1 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 4 month | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 7 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 10 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.30M 10-Q · filed 2026-08-12 | $2.05M 10-Q · filed 2026-08-12 | $2.17M derived: sum of 3 quarters · filed 2026-08-12 | $2.23M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2026-03-31 | $749.81K 10-Q · filed 2026-05-08 | $864.24K derived: sum of 2 quarters · filed 2026-05-08 | $926.07K derived: sum of 3 quarters · filed 2026-05-08 | $1.04M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-12-31 | $114.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $176.25K derived: sum of 2 quarters · filed 2026-03-31 | $292.64K derived: sum of 3 quarters · filed 2026-08-12 | $368.17K 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | $61.83K 10-Q · filed 2025-11-14 | $178.21K derived: sum of 2 quarters · filed 2026-08-12 | $253.74K 10-Q · filed 2025-11-14 | $429.08K derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-06-30 | $116.38K 10-Q · filed 2026-08-12 | $191.91K 10-Q · filed 2026-08-12 | $367.26K derived: sum of 3 quarters · filed 2026-08-12 | $504.49K derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-03-31 | $75.53K 10-Q · filed 2026-05-08 | $250.88K derived: sum of 2 quarters · filed 2026-05-08 | $388.11K derived: sum of 3 quarters · filed 2026-05-08 | $602.56K derived: sum of 4 quarters · filed 2026-05-08 | ||||||||
| 2024-12-31 | $175.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $312.58K derived: sum of 2 quarters · filed 2026-03-31 | $527.02K derived: sum of 3 quarters · filed 2026-03-31 | $770.03K 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | $137.23K 10-Q · filed 2025-11-14 | $351.68K derived: sum of 2 quarters · filed 2025-11-14 | $594.68K 10-Q · filed 2025-11-14 | $654.64K derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | $214.45K 10-Q · filed 2025-08-12 | $457.45K 10-Q · filed 2025-08-12 | $517.40K derived: sum of 3 quarters · filed 2025-08-12 | $1.55M derived: sum of 4 quarters · filed 2025-08-12 | ||||||||
| 2024-03-31 | $243.00K 10-Q · filed 2025-05-14 | $302.95K derived: sum of 2 quarters · filed 2025-05-14 | $1.34M derived: sum of 3 quarters · filed 2025-05-14 | $3.69M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2023-12-31 | $59.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $1.10M derived: sum of 2 quarters · filed 2025-03-21 | $3.45M derived: sum of 3 quarters · filed 2025-03-21 | $7.17M 10-K · filed 2025-03-21 | ||||||||
| 2023-09-30 | $1.04M 10-Q · filed 2024-11-14 | $3.39M derived: sum of 2 quarters · filed 2024-11-14 | $7.11M 10-Q · filed 2024-11-14 | $11.80M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||
| 2023-06-30 | $2.35M 10-Q · filed 2024-08-09 | $6.08M 10-Q · filed 2024-08-09 | $10.76M derived: sum of 3 quarters · filed 2024-08-09 | $14.55M derived: sum of 4 quarters · filed 2024-08-09 | ||||||||
| 2023-03-31 | $3.73M 10-Q · filed 2024-05-13 | $8.41M derived: sum of 2 quarters · filed 2024-05-13 | $12.20M derived: sum of 3 quarters · filed 2024-05-13 | $15.12M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2022-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $8.48M derived: sum of 2 quarters · filed 2024-03-22 | $11.40M derived: sum of 3 quarters · filed 2024-03-22 | $15.84M 10-K · filed 2024-03-22 | ||||||||
| 2022-09-30 | $3.79M 10-Q · filed 2023-11-09 | $6.71M derived: sum of 2 quarters · filed 2023-11-09 | $11.15M 10-Q · filed 2023-11-09 | $13.85M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||
| 2022-06-30 | $2.92M 10-Q · filed 2023-08-10 | $7.36M 10-Q · filed 2023-08-10 | $10.06M derived: sum of 3 quarters · filed 2023-08-10 | $12.07M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | $4.44M 10-Q · filed 2023-05-11 | $7.14M derived: sum of 2 quarters · filed 2023-05-11 | $9.15M derived: sum of 3 quarters · filed 2023-05-11 | $11.25M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||
| 2021-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $4.71M derived: sum of 2 quarters · filed 2023-03-27 | $6.81M derived: sum of 3 quarters · filed 2023-03-27 | $8.55M 10-K · filed 2023-03-27 | ||||||||
| 2021-09-30 | $2.02M 10-Q · filed 2022-11-10 | $4.11M derived: sum of 2 quarters · filed 2022-11-10 | $5.85M 10-Q · filed 2022-11-10 | $7.88M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||
| 2021-06-30 | $2.10M 10-Q · filed 2022-08-05 | $3.84M 10-Q · filed 2022-08-05 | $5.86M derived: sum of 3 quarters · filed 2022-08-05 | $7.66M derived: sum of 4 quarters · filed 2022-08-05 | ||||||||
| 2021-03-31 | $1.74M 10-Q · filed 2022-05-12 | $3.76M derived: sum of 2 quarters · filed 2022-05-12 | $5.57M derived: sum of 3 quarters · filed 2022-05-12 | $7.01M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $3.83M derived: sum of 2 quarters · filed 2022-03-25 | $5.27M derived: sum of 3 quarters · filed 2022-03-25 | $6.91M 10-K · filed 2022-03-25 | ||||||||
| 2020-09-30 | $1.80M 10-Q · filed 2021-11-04 | $3.25M derived: sum of 2 quarters · filed 2021-11-04 | $4.89M 10-Q · filed 2021-11-04 | $6.23M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||
| 2020-06-30 | $1.44M 10-Q · filed 2021-08-05 | $3.09M 10-Q · filed 2021-08-05 | $4.42M derived: sum of 3 quarters · filed 2021-08-05 | $5.57M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||
| 2020-03-31 | $1.64M 10-Q · filed 2021-05-12 | $2.98M derived: sum of 2 quarters · filed 2021-05-12 | $4.12M derived: sum of 3 quarters · filed 2021-05-12 | $4.96M derived: sum of 4 quarters · filed 2021-05-12 | ||||||||
| 2019-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.48M derived: sum of 2 quarters · filed 2021-03-18 | $3.32M derived: sum of 3 quarters · filed 2021-03-18 | $4.02M 10-K · filed 2021-03-18 | ||||||||
| 2019-09-30 | $1.14M 10-Q · filed 2020-11-12 | $1.98M derived: sum of 2 quarters · filed 2020-11-12 | $2.68M 10-Q · filed 2020-11-12 | $2.87M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | $840.14K 10-Q · filed 2020-08-12 | $29.29K 10-Q · filed 2019-07-17 | $1.54M 10-Q · filed 2020-08-12 | $31.00K 10-Q · filed 2019-07-17 | $1.73M derived: sum of 3 quarters · filed 2020-08-12 | $2.08M derived: sum of 4 quarters · filed 2020-08-12 | ||||||
| 2019-03-31 | $699.93K 10-Q/A · filed 2020-05-15 | $1.71K 10-Q · filed 2019-05-01 | $887.69K derived: sum of 2 quarters · filed 2020-05-15 | $1.24M derived: sum of 3 quarters · filed 2020-05-15 | $7.42M derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | $187.76K 10-K · filed 2019-03-06 | $541.37K derived: sum of 2 quarters · filed 2019-11-12 | $6.72M derived: sum of 3 quarters · filed 2019-11-12 | $1.29M 10-K · filed 2020-03-23 | $11.91M 10-K · filed 2019-03-06 | |||||||
| 2018-09-30 | $353.61K 10-Q · filed 2019-11-12 | $865.76K 10-Q · filed 2018-11-05 | $6.53M derived: sum of 2 quarters · filed 2019-11-12 | $803.85K 10-Q · filed 2019-11-12 | $11.72M 10-Q · filed 2018-11-05 | $15.47M derived: sum of 4 quarters · filed 2019-11-12 | ||||||
| 2018-06-30 | $6.17M 10-Q · filed 2019-07-17 | $10.85M 10-Q · filed 2019-07-17 | $15.11M derived: sum of 3 quarters · filed 2019-07-17 | $19.85M derived: sum of 4 quarters · filed 2019-07-17 | ||||||||
| 2018-03-31 | $4.68M 10-Q · filed 2019-05-01 | $8.94M derived: sum of 2 quarters · filed 2019-05-01 | $13.68M derived: sum of 3 quarters · filed 2019-05-01 | $17.76M derived: sum of 4 quarters · filed 2019-05-01 | ||||||||
| 2017-12-31 | $4.26M 10-K · filed 2019-03-06 | $9.00M derived: sum of 2 quarters · filed 2019-03-06 | $13.07M derived: sum of 3 quarters · filed 2019-03-06 | $16.99M 10-K · filed 2019-03-06 | ||||||||
| 2017-09-30 | $4.74M 10-K · filed 2019-03-06 | $8.82M derived: sum of 2 quarters · filed 2019-03-06 | $12.73M 10-Q · filed 2018-11-05 | $16.96M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-06-30 | $4.08M 10-K · filed 2019-03-06 | $7.99M 10-Q · filed 2018-08-01 | $12.22M derived: sum of 3 quarters · filed 2019-03-06 | $17.89M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-03-31 | $3.91M 10-K · filed 2019-03-06 | $8.15M derived: sum of 2 quarters · filed 2019-03-06 | $13.81M derived: sum of 3 quarters · filed 2019-03-06 | $19.91M derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2016-12-31 | $4.23M 10-K · filed 2018-03-07 | $9.90M derived: sum of 2 quarters · filed 2018-03-07 | $15.99M derived: sum of 3 quarters · filed 2018-03-07 | $20.38M 10-K · filed 2019-03-06 | ||||||||
| 2016-09-30 | $5.67M 10-K · filed 2018-03-07 | $11.76M derived: sum of 2 quarters · filed 2018-03-07 | $16.15M 10-Q · filed 2017-11-06 | $19.46M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-06-30 | $6.09M 10-K · filed 2018-03-07 | $10.48M 10-Q · filed 2017-08-02 | $13.79M derived: sum of 3 quarters · filed 2018-03-07 | $17.24M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-03-31 | $4.39M 10-K · filed 2018-03-07 | $7.70M derived: sum of 2 quarters · filed 2018-03-07 | $11.14M derived: sum of 3 quarters · filed 2018-03-07 | $14.33M derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2015-12-31 | $3.31M 10-K · filed 2017-03-08 | $6.75M derived: sum of 2 quarters · filed 2017-03-08 | $9.94M derived: sum of 3 quarters · filed 2017-03-08 | $12.75M 10-K · filed 2018-03-07 | ||||||||
| 2015-09-30 | $3.45M 10-K · filed 2017-03-08 | $6.64M derived: sum of 2 quarters · filed 2017-03-08 | $9.44M 10-Q · filed 2016-11-02 | $11.41M derived: sum of 4 quarters · filed 2017-03-08 | ||||||||
| 2015-06-30 | $3.19M 10-K · filed 2017-03-08 | $6.00M 10-Q · filed 2016-08-03 | $7.96M derived: sum of 3 quarters · filed 2017-03-08 | $8.87M derived: sum of 4 quarters · filed 2017-03-08 | ||||||||
| 2015-03-31 | $2.80M 10-K · filed 2017-03-08 | $4.77M derived: sum of 2 quarters · filed 2017-03-08 | $5.68M derived: sum of 3 quarters · filed 2017-03-08 | $6.78M derived: sum of 4 quarters · filed 2017-03-08 | ||||||||
| 2014-12-31 | $1.97M 10-K · filed 2016-03-08 | $2.87M derived: sum of 2 quarters · filed 2016-03-08 | $3.97M derived: sum of 3 quarters · filed 2016-03-08 | $4.00M 10-K · filed 2017-03-08 | ||||||||
| 2014-09-30 | $909.12K 10-K · filed 2016-03-08 | $2.01M derived: sum of 2 quarters · filed 2016-03-08 | $2.04M 10-Q · filed 2015-11-04 | |||||||||
| 2014-06-30 | $1.10M 10-K · filed 2016-03-08 | $1.13M 10-Q · filed 2015-08-05 | ||||||||||
| 2014-03-31 | $30.02K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |